What Is argenx SE (ARGX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, argenx SE's intrinsic value is estimated at $572.03. Trading at its current price of $876.25, the valuation engine raises significant caution: 10 of 13 models flag downside risk, projecting an average implied return of -34.7%. The most optimistic model, Markov DDM, places fair value at $1,724.33 (+96.8%), while ML-RIV — the most conservative — estimates $21.62 (-97.5%). This +194.3% gap reflects genuine analytical uncertainty about argenx SE's intrinsic worth.
What Do the Models Say About ARGX?
13 of 13 models are currently active for ARGX. Of these, 2 models suggest upside while 11 models suggest overvaluation. The Bayesian DCF estimates ARGX's intrinsic value at $575.70, implying -34.3% downside from the current price. See which stocks rank higher →
How Does ARGX Rank in Biotechnology?
Among 62 Biotechnology stocks, ARGX ranks #58 by Quality of Company score. CirclFi's QOC score of 2.2/10 evaluates 32 fundamental signals. A score of 2.2 signals below-average fundamentals.
See all Most Undervalued Biotechnology Stocks →
The Biotechnology sector introduces analytical considerations specific to biotech businesses. For argenx SE, metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.
Is ARGX a Value Trap?
The Value Trap algorithm is not active for ARGX. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for argenx SE. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, argenx SE scores 2.2 out of 10 on our 32-signal quality assessment, a weak rating that exhibits fundamental weaknesses that warrant careful scrutiny. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +194.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ARGX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ARGX's 13 active models, average confidence is 9%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad